1-11 of 11
Guillermo Drelichman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Experience with Blinatumomab in Pediatric Patients in Argentina. Multi-Center Study

Luisina Peruzzo, Maria Sara Felice, Jorge Rossi, Guillermo Drelichman, Lorena Moran, Cecilia Riccheri, Ezequiel Recondo, Virginia Schuttenberg
Journal: Blood
Blood (2023) 142 (Supplement 1): 5886.
https://doi.org/10.1182/blood-2023-188917
Published: 2023
Journal Articles

Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy

Clinical Trials & Observations
Timothy M. Cox, Guillermo Drelichman, Renata Cravo, Manisha Balwani, Thomas Andrew Burrow, Ana Maria Martins, Elena Lukina, Barry Rosenbloom, Ozlem Goker-Alpan, Nora Watman, Amal El-Beshlawy, Priya S. Kishnani, Maria Lucia Pedroso, Sebastiaan J. M. Gaemers, Regina Tayag, M. Judith Peterschmitt
Journal: Blood
Blood (2017) 129 (17): 2375–2383.
https://doi.org/10.1182/blood-2016-12-758409
Published: 2017
Journal Articles

Encore: A Randomized, Controlled, Open-Label Non-Inferiority Study Comparing Eliglustat To Imiglucerase In Gaucher Disease Type 1 Patients On Enzyme Replacement Therapy Who Have Reached Therapeutic Goals

Thomas Andrew Burrow, MD, FAAP, FACMG, Manisha Balwani, MD, MS, Timothy M. Cox, MD, Guillermo Drelichman, MD, Renata Cravo, MD, Ana Maria Martins, MD, PhD, Elena Lukina, MD, PhD, Barry E. Rosenbloom, MD, Leorah H. Ross, MD, PhD, Jennifer Angell, ScM, Ana Cristina Puga, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3468.
https://doi.org/10.1182/blood.V122.21.3468.3468
Published: 2013
Journal Articles

Comparison of IV Busulfan and Fludarabine Vs Oral Busulfan Plus Cyclophosphamide As Myeloablative Conditioning Regimens for Acute Leukemias and Myelodisplastic Syndromes

Gregorio Jaimovich, Alejandro Requejo, Vera Milovic, Nicolas Fernandez Escobar, Guillermo Drelichman, Juan Real, Sandra Brioschi, Leonardo Julio Feldman, Sr., MD
Journal: Blood
Blood (2011) 118 (21): 4575.
https://doi.org/10.1182/blood.V118.21.4575.4575
Published: 2011
Journal Articles

Minimal Residual Disease by Flow Cytometry in Children with Acute Lymphoblastic Leukemia. Single-Center Experience

Marcela Eugenia Soria, Marcela Ema Gutierrez, Maria Isabel Gaillard, Maria Cores, Gimena Gil, Lorena Elizabeth Moran, Maria Fernanda Rivas Pereira, Silvina Prada, Guillermo Drelichman, MD, Leonardo Feldman, MD, Luis Alberto Aversa
Journal: Blood
Blood (2011) 118 (21): 4238.
https://doi.org/10.1182/blood.V118.21.4238.4238
Published: 2011
Journal Articles

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up

Clinical Trials & Observations
M. Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, Duran Canatan, Marcello Capra, Alan Cohen, Guillermo Drelichman, Marina Economou, Slaheddine Fattoum, Antonis Kattamis, Yurdanur Kilinc, Silverio Perrotta, Antonio Piga, John B. Porter, Louis Griffel, Victor Dong, Joan Clark, Yesim Aydinok
Journal: Blood
Blood (2011) 118 (4): 884–893.
https://doi.org/10.1182/blood-2010-11-316646
Published: 2011
Includes: Supplemental data
Journal Articles

Lipid Peroxidation Products In Bone Marrow Plasma (BMp) and Peripheral Blood Plasma (PBp) From Patients with Low Risk Myelodysplastic Syndrome (MDS)

Leonardo Julio Feldman, Sr., MD, Edgardo Rodriguez, Aldo Sansinanea, Vera Milovic, Gregorio Jaimovich, Guillermo Drelichman, Juan Real, Dolores Puente, Alejandro Requejo
Journal: Blood
Blood (2010) 116 (21): 2924.
https://doi.org/10.1182/blood.V116.21.2924.2924
Published: 2010
Journal Articles

Efficacy and Safety of Deferasirox (Exjade®) in Patients with β-Thalassemia Major Treated for up to 5 Years.

M. Domenica Cappellini, Silverio Perrotta, Leyla Agaoglu, Yesim Aydinok, Marcello Capra, Duran Canatan, Guillermo Drelichman, Yurdanur Kilinc, Carmelo Magnano, John B. Porter, Antonio Piga, Louis Griffel, Darlene Lagrone, Joan Clark, Antonis Kattamis
Journal: Blood
Blood (2009) 114 (22): 4063.
https://doi.org/10.1182/blood.V114.22.4063.4063
Published: 2009
Journal Articles

Autologous Hemopoietic Stem-Cell Transplantation in Patients with Preexisting Cardiac Abnormalities.

Leonardo Feldman, MD, Alejandro M. Requejo, MD, Gregorio Jaimovich, MD, Vera Milovic, MD, Bonini Nicolas, MD, Puente Dolores, MD, Viviana Listello, MD, Guillermo Drelichman, MD
Journal: Blood
Blood (2006) 108 (11): 2982.
https://doi.org/10.1182/blood.V108.11.2982.2982
Published: 2006
Journal Articles

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia

Clinical Trials & Observations
Maria Domenica Cappellini, Alan Cohen, Antonio Piga, Mohamed Bejaoui, Silverio Perrotta, Leyla Agaoglu, Yesim Aydinok, Antonis Kattamis, Yurdanur Kilinc, John Porter, Marcello Capra, Renzo Galanello, Slaheddine Fattoum, Guillermo Drelichman, Carmelo Magnano, Monica Verissimo, Miranda Athanassiou-Metaxa, Patricia Giardina, Alexandra Kourakli-Symeonidis, Gritta Janka-Schaub, Thomas Coates, Christiane Vermylen, Nancy Olivieri, Isabelle Thuret, Herbert Opitz, Catherine Ressayre-Djaffer, Peter Marks, Daniele Alberti
Journal: Blood
Blood (2006) 107 (9): 3455–3462.
https://doi.org/10.1182/blood-2005-08-3430
Published: 2006
Journal Articles

Management of Hereditary Spherocytosis in a Public Health Care Provider in a Developing Country.

Leonardo Feldman, MD, Guillermo Drelichman, MD, Nora Basack, MD, Ernesto Rodriguez, MD, Daniel Freigeiro, MD, Luis Aversa, MD
Journal: Blood
Blood (2005) 106 (11): 3752.
https://doi.org/10.1182/blood.V106.11.3752.3752
Published: 2005